Sign inGet started

Slover Peter T

Insider CIK 1468012 · SPHS Chief Financial Officer · CTNM Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CTNM Contineum Therapeutics, In A Award deriv2026-01-302026-01-30192,000— $0192,000SEC↗
CTNM Contineum Therapeutics, In A Award deriv2025-01-312025-01-31110,000— $0110,000SEC↗
CTNM Contineum Therapeutics, In A Award deriv2024-05-242024-05-29100,000— $0100,000SEC↗
SPHS SOPHIRIS BIO INC. A Award deriv2019-12-192019-12-23103,000$0.36 $37.1K103,000SEC↗
SPHS SOPHIRIS BIO INC. A Award deriv2018-12-312019-01-03205,667— $0205,667SEC↗
SPHS SOPHIRIS BIO INC. A Award deriv2017-12-062017-12-0812,768— $012,768SEC↗
SPHS SOPHIRIS BIO INC. A Award deriv2016-12-072016-12-09154,000— $0154,000SEC↗
SPHS SOPHIRIS BIO INC. A Award deriv2016-05-272016-06-01103,467— $0103,467SEC↗
SPHS SOPHIRIS BIO INC. A Award deriv2015-02-052015-02-0637,058— $037,058SEC↗
SPHS SOPHIRIS BIO INC. A Award deriv2013-10-252013-10-29147,727— $0147,727SEC↗
SPHS SOPHIRIS BIO INC. P Buy2013-08-202013-08-204,680$4.25 $19.9K4,680SEC↗